Efficacy in BRCAWT tumours is likely due to BRCAness, a phenotype similar to BRCAMUT, with a defect in homologous recombination repair, but actually lack the mutation in BRCA1/2 [25]. This evidence concerns the gene BRCA1 and neoplasm.